$SPRC

$4.41▲ +1.8% YTD

4 SEC 13D/G filings tracked · Last updated Oct 7, 2026

Filing History

CP $4.41▲ +1.8%Oct 7, 2026 · ThinkSabio Blog

$SPRC - SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-Wor…

News

SPRC ▲ +1.5% - SciSparc Ltd.

CP $4.64▲ +1.5%Sep 23, 2026 · ThinkSabio Blog

$SPRC - SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine an…

News

SPRC ▼ -4.8% - SciSparc Ltd.

CP $5.50▲ -4.8%Sep 2, 2026 · ThinkSabio Blog

$SPRC - SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affai…

News

SPRC ▼ -2.6% - SciSparc Ltd.

CP $6.41▲ -2.6%Aug 31, 2026 · ThinkSabio Blog

$SPRC - SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI?210 Autism Clinical Trial…